Role of ZBP1 in pathogenesis of Salmonella biofilms
ZBP1 在沙门氏菌生物膜发病机制中的作用
基本信息
- 批准号:10658383
- 负责人:
- 金额:$ 84.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-11 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAmyloidAnkylosing spondylitisAutoantibodiesAutoimmunityB-DNABacterial DNABacterial InfectionsBindingCampylobacterCell DeathCellsCessation of lifeChronicClinicalComplexDNADiseaseEpithelial CellsFibroblastsGastrointestinal tract structureGenerationsGenomic DNAHumanIL17 geneImmuneIndividualIndustrializationInfectionInflammationInflammation MediatorsInflammatoryInterferon Type ILeftLigandsMediatingMicrobial BiofilmsMorbidity - disease rateMusNatureNucleic AcidsOutcomePainPathogenesisPathway interactionsPatientsPhenotypePhosphotransferasesPositioning AttributePreventiveProcessProductionProtein SecretionProteinsRIPK3 geneRNAReiter DiseaseReportingRoleSalmonellaSalmonella entericaSalmonella infectionsSalmonella typhimuriumShigellaSignal TransductionSymptomsTestingTherapeuticTherapeutically TargetableViral ProteinsVirus DiseasesYersiniaZ-Form DNAacute infectioncell typechronic infectionchronic inflammatory diseaseds-DNAenteric infectionenteric pathogengastrointestinal symptomimmunogenicinhibitorintestinal epitheliumjoint inflammationkinase inhibitormodel organismmortalitymouse modelmutantnovel therapeuticspreventresponsesensorsmall moleculesystemic inflammatory response
项目摘要
PROJECT SUMMARY
Infections with enteric pathogens such as Salmonella, Campylobacter, Shigella, or Yersinia are leading causes
of morbidity and mortality worldwide. Although in most individuals the infection resolves, approximately 5% of
patients subsequently develop a painful chronic inflammatory condition known as Reactive Arthritis (ReA). How
Salmonella infections trigger ReA is not well understood. Using Salmonella enterica serovar Typhimurium (STm)
as a model organism, we discovered that a Salmonella protein, curli, is a dominant instigator of inflammation
following Salmonella infection. Curli is a secreted protein and major component of the STm biofilm in the
gastrointestinal tract. Curli fibrils bind extruded bacterial DNA within the biofilm. It is these curli:DNA complexes,
rather than curli alone, that are potent triggers of type I interferon, IL-17, and anti-double stranded DNA
autoantibody production, leading to ReA. Unknown, however, is why curli:DNA complexes are so inflammatory.
We report in this proposal the remarkable discovery that the DNA present within curli:DNA complexes is not
solely B-DNA, the classic right-handed (Watson-Crick) double-helix, but includes copious amounts of left-handed
Z-DNA as well. Z-form nucleic acids, such as Z-DNA and Z-RNA, were thought not to readily occur in nature,
until we showed last year that Z-RNA is indeed produced during virus infections and is a ligand for the
necroptosis-activating host sensor protein ZBP1. Our preliminary results now show that the Z-DNA within
curli:DNA complexes activates ZBP1 in intestinal epithelial cells (IECs) and fibroblasts, resulting in RIPK3-
dependent necroptosis of these cells. These findings allow us to put forward the hypothesis that Z-DNA within
curli:DNA fibrils in Salmonella biofilms activates ZBP1 to instigate RIPK3-dependent necroptosis in intestinal
epithelial cells (IECs) and other cell types. Necroptosis, in turn, causes cell loss and disrupts gut barrier integrity,
releasing inflammatory mediators that eventually result in autoimmunity and ReA. As necroptosis is a highly
inflammatory mode of cell death, these findings, at long last, supply a plausible mechanism for why curli:DNA
complexes are hyperinflammatory, and, therefore, for how Salmonella triggers ReA. They also identify Z-DNA
as a new PAMP, implicate ZBP1 – until now considered an antiviral protein – as a sensor of bacterial infections,
and position RIPK3 inhibitors as unanticipated new therapeutics for the treatment of ReA. In aim 1, we will
determine how Z-DNA forms within curli:DNA complexes, and how Z-DNA activates ZBP1. In aim 2, we will
identify the ZBP1-driven immune pathways that promote curli:DNA induced inflammation and ReA, and
determine the cell types in which ZBP1 signaling is important for pathogenesis. In aim 3, we will evaluate whether
necroptosis blockade with RIPK3 kinase inhibitors will have preventive or therapeutic benefit in ReA. A
successful outcome to these studies will outline an entirely new mechanism of Salmonella-triggered
inflammation. They also stand to open up exciting new therapeutic avenues for Salmonella-induced ReA, with
potentially game-changing ramifications for this currently incurable disease.
项目摘要
感染肠道病原体,如沙门氏菌,弯曲杆菌,志贺氏菌,或耶尔森氏菌是主要原因
的发病率和死亡率。虽然在大多数人的感染解决,约5%的
患者随后发展为称为反应性关节炎(ReA)的疼痛性慢性炎症。如何
沙门氏菌感染触发ReA还不清楚。使用肠道沙门氏菌鼠伤寒血清型(STm)
作为一种模式生物,我们发现沙门氏菌的一种蛋白质curli是炎症的主要诱因
沙门氏菌感染后。Curli是一种分泌性蛋白,是STm生物膜的主要成分,
胃肠道卷曲原纤维结合生物膜内挤出的细菌DNA。正是这些卷曲的DNA复合物,
而不是单独的curli,它们是I型干扰素、IL-17和抗双链DNA的有效触发剂,
自身抗体产生,导致ReA。然而,未知的是为什么curli:DNA复合物如此具有炎症性。
我们在这个建议中报告了一个引人注目的发现,即存在于curli:DNA复合物中的DNA不是
只有B-DNA,经典的右手(沃森-克里克)双螺旋,但包括大量的左手
Z-DNA也是。Z型核酸,如Z-DNA和Z-RNA,被认为不容易在自然界中出现,
直到去年,我们才证明Z-RNA确实是在病毒感染过程中产生的,并且是病毒的配体。
坏死性凋亡激活宿主传感器蛋白ZBP 1。我们的初步结果显示,
curli:DNA复合物激活肠上皮细胞(IEC)和成纤维细胞中的ZBP 1,导致RIPK 3-
这些细胞的依赖性坏死性凋亡这些发现使我们能够提出假设,
curli:沙门氏菌生物膜中的DNA原纤维激活ZBP 1以引发肠道中RIPK 3依赖性坏死性凋亡
上皮细胞(IEC)和其他细胞类型。坏死性凋亡,反过来,导致细胞损失和破坏肠道屏障的完整性,
释放炎症介质,最终导致自身免疫和ReA。由于坏死性凋亡是一种高度
炎症模式的细胞死亡,这些发现,终于提供了一个合理的机制,为什么卷曲:DNA
复合物是高度炎症的,因此,沙门氏菌如何触发ReA。它们还能识别Z-DNA
作为一种新的PAMP,涉及ZBP 1-直到现在被认为是一种抗病毒蛋白-作为细菌感染的传感器,
并将RIPK 3抑制剂定位为治疗ReA的未预料到的新疗法。在目标1中,
确定Z-DNA如何在curli:DNA复合物中形成,以及Z-DNA如何激活ZBP 1。在目标2中,我们
鉴定促进curli:DNA诱导的炎症和ReA的ZBP 1驱动的免疫途径,以及
确定ZBP 1信号传导对发病机制重要的细胞类型。在目标3中,我们将评估
用RIPK 3激酶抑制剂阻断坏死性凋亡将在ReA中具有预防或治疗益处。一
这些研究的成功结果将概述沙门氏菌触发的一种全新的机制,
炎症它们还将为沙门氏菌诱导的ReA开辟令人兴奋的新治疗途径,
对于这种目前无法治愈的疾病来说,这可能会改变游戏规则。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SIDDHARTH BALACHANDRAN其他文献
SIDDHARTH BALACHANDRAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SIDDHARTH BALACHANDRAN', 18)}}的其他基金
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
ZBP1 驱动的核坏死性凋亡的小分子开发用于癌症免疫治疗
- 批准号:
10586659 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness
利用 ZBP1 触发的细胞死亡来增强流感疫苗的反应性
- 批准号:
10884586 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy
SARS-CoV-2 发病机制、进化和治疗中的坏死性凋亡
- 批准号:
10433040 - 财政年份:2022
- 资助金额:
$ 84.61万 - 项目类别:
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy
SARS-CoV-2 发病机制、进化和治疗中的坏死性凋亡
- 批准号:
10557863 - 财政年份:2022
- 资助金额:
$ 84.61万 - 项目类别:
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy
利用 ZBP1 驱动的细胞死亡来提高流感疫苗的功效
- 批准号:
10455196 - 财政年份:2021
- 资助金额:
$ 84.61万 - 项目类别:
Targeting RIPK3 in Flu-Associated Lung Injury
靶向 RIPK3 治疗流感相关肺损伤
- 批准号:
10020307 - 财政年份:2019
- 资助金额:
$ 84.61万 - 项目类别:
Targeting RIPK3 in Flu-Associated Lung Injury
靶向 RIPK3 治疗流感相关肺损伤
- 批准号:
10470746 - 财政年份:2019
- 资助金额:
$ 84.61万 - 项目类别:
Targeting RIPK3 in Flu-Associated Lung Injury
靶向 RIPK3 治疗流感相关肺损伤
- 批准号:
10689229 - 财政年份:2019
- 资助金额:
$ 84.61万 - 项目类别:
Targeting RIPK3 in Flu-Associated Lung Injury
靶向 RIPK3 治疗流感相关肺损伤
- 批准号:
10238084 - 财政年份:2019
- 资助金额:
$ 84.61万 - 项目类别:
Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death
甲型流感病毒激活的细胞死亡的机制、功能和利用
- 批准号:
10247652 - 财政年份:2017
- 资助金额:
$ 84.61万 - 项目类别:
相似国自然基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
- 批准号:81870666
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
- 批准号:81601123
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
- 批准号:30971012
- 批准年份:2009
- 资助金额:35.0 万元
- 项目类别:面上项目
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
- 批准号:30570622
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating the function of a protective protein in a novel in vitro reconstitution system for disaggregation of ubiquitinated amyloid fibrils
阐明保护蛋白在新型体外重构系统中用于解聚泛素化淀粉样蛋白原纤维的功能
- 批准号:
24K10522 - 财政年份:2024
- 资助金额:
$ 84.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
新規amyloid-β抑制因子ILEIの減少に伴うアルツハイマー病リスクと分子制御機構の解析
新型β淀粉样蛋白抑制剂ILEI降低相关阿尔茨海默病风险及分子调控机制分析
- 批准号:
23K06805 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Extracting the detrimental effects of amyloid beta oligomer using contextual learning and controlling it with antagonist molecules
使用情境学习提取β淀粉样蛋白寡聚体的有害影响并用拮抗剂分子控制它
- 批准号:
23K06348 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of inhibitors for amyloid peptide aggregation based on peptidomimetics
基于拟肽的淀粉样肽聚集抑制剂的开发
- 批准号:
23K14318 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effect of abnormal beta-amyloid on Ca dynamics in neural cells
异常β-淀粉样蛋白对神经细胞钙动力学的影响
- 批准号:
23K14744 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel functions of presenilin in ApoE secretion and brain amyloid removal
阐明早老素在 ApoE 分泌和脑淀粉样蛋白去除中的新功能
- 批准号:
23KF0156 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
- 批准号:
10722422 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Probing Amyloid Fibril Self-Assembly with Network Hamiltonian Simulations in Explicit Space
用显式空间中的网络哈密顿模拟探测淀粉样蛋白原纤维的自组装
- 批准号:
10715891 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 84.61万 - 项目类别: